Relay Therapeutics, Inc. RLAY Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s investment proceeds?
- Relay Therapeutics, Inc. (RLAY) reported investment proceeds of $83.8M in Q1 2026.
- How has Relay Therapeutics, Inc.'s investment proceeds changed year-over-year?
- Relay Therapeutics, Inc.'s investment proceeds increased by 29.3% year-over-year, from $64.82M to $83.8M.
- What is the long-term trend for Relay Therapeutics, Inc.'s investment proceeds?
- Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s investment proceeds has grown at a -12.1% compound annual growth rate (CAGR), from $529.92M to $316.18M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.